How to buy Taysha Gene Therapies shares | $27.18

Own Taysha Gene Therapies shares in just a few minutes. Share price changes are updated daily.

Taysha Gene Therapies, Inc (TSHA) is a leading biotechnology business based in the US. It opened the day at $27.4 after a previous close of $26.69. During the day the price has varied from a low of $26.975 to a high of $28.9899. The latest price was $27.18 (25 minute delay). Taysha Gene Therapies is listed on the NASDAQ and employs 38 staff. All prices are listed in US Dollars.

How to buy shares in Taysha Gene Therapies

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: TSHA in this case.
  5. Research Taysha Gene Therapies shares. The platform should provide the latest information available.
  6. Buy your Taysha Gene Therapies shares. It's that simple.
The whole process can take as little as 15 minutes.

Taysha Gene Therapies share price

Use our graph to track the performance of TSHA stocks over time.

Taysha Gene Therapies shares at a glance

Information last updated 2021-03-11.
Open$27.4
High$28.9899
Low$26.975
Close$27.18
Previous close$26.69
Change $0.49
Change % 1.8359%
Volume 14,873
Information last updated 2021-04-23.
52-week range$18.16 - $33.35
50-day moving average $23.3477
200-day moving average $24.1008
Wall St. target price$45.1
Dividend yield N/A (0%)
Earnings per share (TTM) N/A
Promoted
eToro Free Stocks

Invest in Taysha Gene Therapies shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes

Fees for buying 50x Taysha Gene Therapies shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $200 £4.82
£968.49 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.54
£965.20 total
Capital at risk
Stake logo £0 £50 £4.96
£968.63 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £21.73
£985.40 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £22.59
£986.25 total
Capital at risk
Fineco logo £0 No minimum £9.64
£973.30 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £21.69
£985.35 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Taysha Gene Therapies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Taysha Gene Therapies price performance over time

Historical closes compared with the last close of $27.18

1 month (2021-04-16) 13.91%
3 months (2021-02-12) -7.52%
6 months (2020-11-13) 33.24%

Financials

Gross profit TTM $0
Return on assets TTM -20.76%
Return on equity TTM -47.79%
Profit margin 0%
Market capitalisation $906.8 million

TTM: trailing 12 months

How to short and sell Taysha Gene Therapies shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "TSHA.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.4 million Taysha Gene Therapies shares held short by investors – that's known as the "short interest". This figure is 7.5% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Taysha Gene Therapies shares can be evaluated.

Short interest ratio (SIR)

Taysha Gene Therapies's "short interest ratio" (SIR) is the quantity of Taysha Gene Therapies shares currently shorted divided by the average quantity of Taysha Gene Therapies shares traded daily (recently around 76118.041511442). Taysha Gene Therapies's SIR currently stands at 18.79. In other words for every 100,000 Taysha Gene Therapies shares traded daily on the market, roughly 18790 shares are currently held short.

However Taysha Gene Therapies's short interest can also be evaluated against the total number of Taysha Gene Therapies shares, or, against the total number of tradable Taysha Gene Therapies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Taysha Gene Therapies's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Taysha Gene Therapies shares in existence, roughly 40 shares are currently held short) or 0.0875% of the tradable shares (for every 100,000 tradable Taysha Gene Therapies shares, roughly 88 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Taysha Gene Therapies.

Find out more about how you can short Taysha Gene Therapies stock.

Taysha Gene Therapies share dividends

We're not expecting Taysha Gene Therapies to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site